Development

Ana Aslan

Life History - Part 16

 

 

The Institute
The Institute

The Institute was situated in a sprawling building which had been erected in 1894 by order of Queen Elisabeth, the wife of Charles I of Hohenzollern. It consisted of a 70m long rectangular building with 3 storeys. The long passage was decorated with mosaics and the outer faćade bore the symbols of all the regions of Rumania in green terracotta. The structure of the building complemented the requirements of the Institute perfectly. There was a hospital section with 70 beds, a care centre with 110 beds, as well as a department for outpatients. Management, organisation and research as well as the future of the Institute, was soon completely under Ana Aslan's control, while Parhon remained in an advisory position. She introduced departments for “Clinical Gerontology” and for the “Biology of Ageing”. Dr Cornel David, who had studied with Prof Vaques in France, and Prof Volhard in Munich, became the Senior Medical Officer for the hospital clinic. Later, he became Deputy Director and remained in that position until 1974. In the Department for “Biology of Ageing” laboratories were established for Physiology, Immunology, Biochemistry, Bio- Physics, Genetics and Tissue Culture. In an annex there was a special laboratory for animal experiments with rabbits, rats and guinea pigs.

 

With 20 patients in care, Ana Aslan executed continuing examinations and treatments over decades. By 1969, this group had grown to 110 cases, and in 1989 there were still 29 patients under observation. The outpatient department was set up to provide geriatric care for the whole of Bucharest. Another special laboratory for Pathology and Histo-Chemistry (the Science of the Structure of Tissue) was begun. Ana Aslan, however, wanted to do much more than lead a good clinic. In many discussions with Parhon, more far-reaching dreams emerged. She wanted everyone to profit by her method, not only when the symptoms of age-related related degeneration appeared, but before in a preventative action. She dreamed about a prophylactic health system, free to everyone, which would give them the chance to age in dignity and health.

 

Abbildung: Gero-H3-Aslan
Gero-H3-Aslan

In 1957, the preparation was marketed with which Ana Aslan treated her patients: Gero-H3-Aslan. Together with the chemist Elena Polovrageanu, they succeeded in stabilising the Procain molecule in a new chemical formula. With that, Grovital H3 was born, a product that was to go around the world and has been imitated more than 150 times up to today. In July 1958, Ana Aslan submitted the protocol of the research to the state Bureau for Inventions, and on the 19th November 1958, the patent was issued for “Gerovital H3: Procain product for the Treatment of Ageing and other Metabolic Diet-Related Illnesses” as listed under the Number 42270.

 

<< back     continue >>
Starting Page > Ana Aslan > Development